Seeing Is Believing
RNA is currently covered by 12 analysts with an average price target of $91.05. This is a potential upside of $18.19 (24.97%) from yesterday's end of day stock price of $72.86.
Avidity Biosciences 's activity chart (see below) currently has 79 price targets and 92 ratings on display. The stock rating distribution of RNA is 73.33% BUY and 26.67% HOLD.
Analysts average stock forecasts to be materialized ratio is 88.96% with an average time for these price targets to be met of 391.53 days.
Highest price target for RNA is $96, Lowest price target is $59, average price target is $70.91.
Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL on 11-Nov-2025. First documented stock forecast 07-Jul-2020.
Currently out of the existing stock ratings of RNA, 22 are a BUY (73.33%), 8 are a HOLD (26.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 28-Oct-2025
$72
$-0.86 (-1.18%)
$72
3 months 12 days ago
(11-Nov-2025)
14/16 (87.5%)
$1.3 (1.84%)
249
Hold Since 29-Oct-2025
$74
$1.14 (1.56%)
$78
3 months 25 days ago
(29-Oct-2025)
2/4 (50%)
$4.35 (6.25%)
439
Hold Since 28-Oct-2025
$72
$-0.86 (-1.18%)
$61
3 months 26 days ago
(28-Oct-2025)
4/4 (100%)
$2.07 (2.96%)
227
Hold Since 27-Oct-2025
$72
$-0.86 (-1.18%)
3 months 27 days ago
(27-Oct-2025)
3/3 (100%)
$2 (2.86%)
969
Hold Since 27-Oct-2025
$65
$-7.86 (-10.79%)
$65
3 months 27 days ago
(27-Oct-2025)
17/18 (94.44%)
$-5 (-7.14%)
255
What is RNA (Avidity Biosciences ) average time for price targets to be met?
Which analyst has the current highest performing score on RNA (Avidity Biosciences ) with a proven track record?
Which analyst has the most public recommendations on RNA (Avidity Biosciences )?
Which analyst is the currently most bullish on RNA (Avidity Biosciences )?
Which analyst is the currently most reserved on RNA (Avidity Biosciences )?